دورية أكاديمية
أعرض في EDS

Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19.

التفاصيل البيبلوغرافية
العنوان: Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19.
المؤلفون: Rosenbaum JE; From SUNY Downstate School of Public Health, Brooklyn, NY., Ochoa KC; the Division of Pediatric Gastroenterology, Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY., Hasan F; the Division of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY., Goldfarb A; the Division of Pediatric Gastroenterology, Department of Pediatrics, New York University, New York, NY., Tang V; the Division of Pediatric Gastroenterology, Department of Pediatrics, Maimonides Medical Center, Brooklyn, NY., Tomer G; the Division of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY., Wallach T; the Division of Pediatric Gastroenterology, Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY.
المصدر: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2023 May 01; Vol. 76 (5), pp. 622-626. Date of Electronic Publication: 2023 Feb 19.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 8211545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-4801 (Electronic) Linking ISSN: 02772116 NLM ISO Abbreviation: J Pediatr Gastroenterol Nutr Subsets: MEDLINE
أسماء مطبوعة: Publication: 2024- : [Hoboken, New Jersey] : Wiley
Original Publication: [New York, N.Y.] : Raven Press, [c1982-
مواضيع طبية MeSH: COVID-19*/epidemiology , Inflammatory Bowel Diseases*/epidemiology , Inflammatory Bowel Diseases*/diagnosis , Crohn Disease*/diagnosis , Colitis, Ulcerative*/diagnosis, Humans ; Child ; New York City/epidemiology
مستخلص: Inflammatory bowel disease (IBD) pathogenesis is thought to be induced by a mix of genetic susceptibility, microbial populations, and immune triggers such as infections. Severe acute respiratory syndrome coronavirus 2 (SARS-nCoV2) may have increased capacity to generate autoimmune disease as evidenced by known spikes in diseases such as type 1 diabetes mellitus. Public health interventions like masking and closures additionally created remarkable drops in typical viral infections, with remarkable shifts in influenza-like illness reporting in 2020. This study aims to evaluate the impact of SARS-nCoV2 and associated interventions on pediatric IBD presentation in New York City using records of new diagnoses at a consortium of 4 institutions between 2016 and June 2022. We fit time series model (autoregressive integrated moving average model) to monthly and quarterly number of cases of each disease for January 2016-March 2020 and forecast the period between April 2020 and June 2022. We note no decrease in ulcerative colitis (UC) or Crohn disease (CD) in the aftermath of historic low levels of overall viral illness, and statistically significant increases in CD diagnoses and elevation in UC diagnoses creating a trend suggesting overall increase in IBD diagnoses exceeding the baseline rate of increase. These data suggest a possible linkage between SARS-nCoV2 infection rates and subsequent pediatric IBD presentation.
Competing Interests: The authors report no conflicts of interest.
(Copyright © 2023 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.)
References: Gottesman BL, Yu J, Tanaka C, et al. Incidence of new-onset type 1 diabetes among US children during the COVID-19 global pandemic. JAMA Pediatr 2022;176:414–5.
Saad MA, Alfishawy M, Nassar M, Mohamed M, Esene IN, Elbendary A. COVID-19 and autoimmune diseases: a systematic review of reported cases. Curr Rheumatol Rev 2021;17:193–204.
Barrett CE, Koyama AK, Alvarez P, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years – United States, March 1, 2020–June 28, 2021. MMWR Morb Mortal Wkly Rep 2022;71:59–65.
Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity. Autoimmun Rev 2020;19:102597.
Aydin MF, Taşdemir H. Ulcerative Colitis in a COVID-19 Patient: A Case Report. Turk J Gastroenterol 2021;32:543–547.
Arostegui D, Castro K, Schwarz S, et al. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Rep 2022;3:e152.
Jacobs JJL. Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses 2021;149:110538.
Kalkeri R, Goebel S, Sharma GD. SARS-CoV-2 shedding from asymptomatic patients: contribution of potential extrapulmonary tissue reservoirs. Am J Trop Med Hyg 2020;103:18–21.
Yusuf F, Fahriani M, Mamada SS, et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: a systematic review and meta-analysis. F1000Res 2021;10:301.
Sun L, Nava GM, Stappenbeck TS. Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease. Curr Opin Gastroenterol 2011;27:321–7.
Sullivan SG, Carlson S, Cheng AC, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill 2020;25:2001847.
Li M, Yuan F. Historical redlining and resident exposure to COVID-19: a study of New York City. Race Soc Probl 2022;14:85–100.
Peaper DR, Murdzek C, Oliveira CR, Murray TS. Severe acute respiratory syndrome coronavirus 2 testing in children in a large regional US health system during the coronavirus disease 2019 pandemic. Pediatr Infect Dis J 2021;40:175–81.
Department of Health New York State. Weekly Influenza Surveillance Report – June 25th, 2022. 2022.
تواريخ الأحداث: Date Created: 20230222 Date Completed: 20230425 Latest Revision: 20230624
رمز التحديث: 20230625
مُعرف محوري في PubMed: PMC10097471
DOI: 10.1097/MPG.0000000000003740
PMID: 36805627
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-4801
DOI:10.1097/MPG.0000000000003740